Rochelle Walensky, MD, MPH, co-director of the MGH Medical Practice Evaluation Center, has been named chief of the Division of Infectious Diseases, effective Sept. 5. She will succeed Stephen Calderwood, MD, who has guided the division for 27 years.
“I am a deeply grateful beneficiary of Dr. Calderwood’s leadership, personally and professionally, and I am thrilled to embrace this next step,” says Walensky. “Steve leaves an indelible legacy within a spectacular division, and I will work tirelessly to ensure MGH’s place as a national and international leader in the field of infectious diseases.”
Walensky is an internationally recognized leader in the clinical and economic outcomes of medical decisions and has made significant contributions in the methods of decision science, Monte Carlo mathematical simulation and cost-effectiveness analyses to promote access to HIV care in the U.S. and abroad.
She has been continuously funded by the NIH since completing her fellowship training and has received substantial recognition for her high-quality translational research. She also is an active teacher and mentor across the MGH and Harvard.
Walensky is a graduate of Johns Hopkins University School of Medicine and the Harvard School of Public Health. She completed her residency in internal medicine at Johns Hopkins Hospital and clinical and research fellowships in Infectious Diseases in the combined Brigham & Women’s Hospital/MGH training program.
Throughout her 16 years at the MGH, she has served as co-director of the Medical Practice Evaluation Center, director of the HIV Clinical Research Conference at the Harvard Center for AIDS Research (CFAR) and the associate director of the Program in Epidemiology and Outcomes in CFAR.
This article was originally published in the 08/18/17 Hotline issue.